140 related articles for article (PubMed ID: 10663584)
21. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
22. [MRI bone marrow findings in 63 patients with type I Gaucher disease].
Poll LW; Willers R; Häussinger D; Mödder U; vom Dahl S
Rofo; 2010 Nov; 182(11):979-85. PubMed ID: 20509100
[TBL] [Abstract][Full Text] [Related]
23. An overview on bone manifestations in Gaucher disease.
Mikosch P; Hughes D
Wien Med Wochenschr; 2010 Dec; 160(23-24):609-24. PubMed ID: 21221913
[TBL] [Abstract][Full Text] [Related]
24. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
26. Gaucher disease with jawbone involvement: a case report.
Ahmadieh A; Farnad F; Sedghizadeh PP
J Med Case Rep; 2014 Nov; 8():360. PubMed ID: 25370695
[TBL] [Abstract][Full Text] [Related]
27. Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density.
Baldini M; Casirati G; Ulivieri FM; Cassinerio E; Khouri Chalouhi K; Poggiali E; Borin L; Burghignoli V; Cesana BM; Cappellini MD
Blood Cells Mol Dis; 2018 Feb; 68():148-152. PubMed ID: 28693786
[TBL] [Abstract][Full Text] [Related]
28. Gaucher Disease in Bone: From Pathophysiology to Practice.
Hughes D; Mikosch P; Belmatoug N; Carubbi F; Cox T; Goker-Alpan O; Kindmark A; Mistry P; Poll L; Weinreb N; Deegan P
J Bone Miner Res; 2019 Jun; 34(6):996-1013. PubMed ID: 31233632
[TBL] [Abstract][Full Text] [Related]
29. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
Kelman CG; Disler DG
J Comput Assist Tomogr; 2000; 24(1):173-5. PubMed ID: 10667678
[TBL] [Abstract][Full Text] [Related]
30. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
Aharoni D; Krausz Y; Elstein D; Hadas-Halpern I; Zimran A
Clin Nucl Med; 2002 Jul; 27(7):503-9. PubMed ID: 12072778
[TBL] [Abstract][Full Text] [Related]
31. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
[TBL] [Abstract][Full Text] [Related]
32. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR.
Allison JW; James CA; Arnold GL; Stine KC; Becton DL; Bell JM
Pediatr Radiol; 1998 Apr; 28(4):237-40. PubMed ID: 9545478
[TBL] [Abstract][Full Text] [Related]
33. D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement.
Sherif EM; Tantawy AA; Adly AA; Kader HA; Ismail EA
Blood Coagul Fibrinolysis; 2011 Apr; 22(3):176-84. PubMed ID: 21346558
[TBL] [Abstract][Full Text] [Related]
34. [Magnetic resonance in the diagnosis of extent and osseous complications of Gaucher's disease type 1].
Roca M; Mota J; Giraldo P; Pérez Calvo J; Gómez Pereda R; Giralt M
Rev Clin Esp; 1997 Aug; 197(8):550-4. PubMed ID: 9312791
[TBL] [Abstract][Full Text] [Related]
35. Gaucher disease: assessment with MR imaging.
Lanir A; Hadar H; Cohen I; Tal Y; Benmair J; Schreiber R; Clouse ME
Radiology; 1986 Oct; 161(1):239-44. PubMed ID: 3763873
[TBL] [Abstract][Full Text] [Related]
36. Jaw involvement in Gaucher disease: a not-so-uncommon feature of a rare disease.
D'Amore S; Kumar N; Ramaswami U
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34785512
[TBL] [Abstract][Full Text] [Related]
37. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
Mikosch P; Kohlfürst S; Gallowitsch HJ; Kresnik E; Lind P; Mehta AB; Hughes DA
Nuklearmedizin; 2008; 47(6):239-47. PubMed ID: 19057797
[TBL] [Abstract][Full Text] [Related]
38. Bone- and bone marrow scintigraphy in Gaucher disease type 1.
Mikosch P; Zitter F; Gallowitsch HJ; Würtz F; Lind P; Mehta AB; Hughes DA
Nuklearmedizin; 2008; 47(4):N39-43. PubMed ID: 18763370
[No Abstract] [Full Text] [Related]
39. Quantification of Bone Marrow Involvement in Treated Gaucher Disease With Proton MR Spectroscopy: Correlation With Bone Marrow MRI Scores and Clinical Status.
Jaramillo D; Bedoya MA; Wang DJ; Pena AH; Delgado J; Jaimes C; Ho-Fung V; Kaplan P
AJR Am J Roentgenol; 2015 Jun; 204(6):1296-302. PubMed ID: 26001241
[TBL] [Abstract][Full Text] [Related]
40. Bone complications in children with Gaucher disease.
Bembi B; Ciana G; Mengel E; Terk MR; Martini C; Wenstrup RJ
Br J Radiol; 2002; 75 Suppl 1():A37-44. PubMed ID: 12036831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
